TITLE

Creeping fat in Crohn's disease: travelling in a creeper lane of research?

AUTHOR(S)
Schäffler, A.; Herfarth, H.
PUB. DATE
June 2005
SOURCE
Gut;Jun2005, Vol. 54 Issue 6, p742
SOURCE TYPE
Academic Journal
DOC. TYPE
Editorial
ABSTRACT
The article discusses about Crohn's disease in relation to deposition of fats. The connective and adipose tissue changes observed in patients with Crohn's disease have received only little attention from pathologists, although fat hypertrophy, fat wrapping--fat creeping upon the bowel, and creeping fat have long been recognized by surgeons as a phenomenon suitable for delineating the extent of active disease. Burril B. Crohn himself, who gave his name to this chronic inflammatory bowel disease, initially described the changes in the appearance of the mesenteric adipose tissue as a characteristic symptom of the disease.
ACCESSION #
17176762

 

Related Articles

  • Information management and informatics: need for a modern pathology service. Jones, Rick; O'Connor, John // Annals of Clinical Biochemistry;May2004, Vol. 41 Issue 3, p183 

    Requirements for information technology in pathology now extend well beyond the provision of purely analytical data. With the aim of achieving seamless integration of laboratory data into the total clinical pathway, 'informatics' - the art and science of turning data into useful information - is...

  • Neuroinflammation in inflammatory bowel disease. Lakhan, Shaheen E.; Kirchgessner, Annette // Journal of Neuroinflammation;2010, Vol. 7, p37 

    Inflammatory bowel disease is a chronic intestinal inflammatory condition, the pathology of which is incompletely understood. Gut inflammation causes significant changes in neurally controlled gut functions including cramping, abdominal pain, fecal urgency, and explosive diarrhea. These symptoms...

  • Growth Impairment in Inflammatory Bowel Disease. Sherlock, Mary; Griffiths, Anne M. // Current Medical Literature: Growth, Growth Hormone, & Metabolism;2008, Vol. 2 Issue 2, p41 

    The article presents information on the prevalence of growth impairment in pediatric inflammatory bowel disease (IBD). It explores the patterns of growth and pubertal progression in young patients with IBD. It explains the standardized monitoring and assessment of growth. It discusses the...

  • Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage. D Foell // Gut;Jun2009, Vol. 58 Issue 6, p859 

    It is a common experience that gastrointestinal symptoms urge us to differentiate inflammatory bowel disease (IBD) from functional disorders. Furthermore, in patients with proven IBD the disease activity has to be accurately monitored. Faecal markers of neutrophil influx into the mucosa are...

  • Coping With Crohn's Disease. Waters, Jen // World & I;Jun/Jul2006, Vol. 21 Issue 6, p20 

    The article considers the cause, diagnosis and treatment of Crohn's disease. Crohn's disease is a type of inflammatory bowel disease, a family of diseases that cause irritation in the intestines. Because the occurrence of Crohn's disease parallels peptic ulcer disease, it would suggest that the...

  • An Antibiotic-Responsive Mouse Model of Fulminant Ulcerative Colitis. Kang, Silvia S; Bloom, Seth M; Norian, Lyse A; Geske, Michael J; Flavell, Richard A; Stappenbeck, Thaddeus S; Allen, Paul M // PLoS Medicine;Mar2008, Vol. 5 Issue 3, pe41 

    Paul Allen and colleagues describe the development of a mouse model of fulminant ulcerative colitis with multiple genetic hits in immune regulation which can be moderated by anti-cytokine therapy and broad-spectrum antibiotics.

  • Inflammatory Bowel Disorders.  // Current Medical Literature: Gastroenterology;2011, Vol. 30 Issue 1, p21 

    The article discusses various research that explored the different aspects of inflammatory bowel disorders. One of the studies dealt with the changes in surgical resection rates and medical treatments for Crohn's disease. Another research focused on the association of pre-operative management...

  • New therapeutic approach in inflammatory bowel disease. PAPA, A.; MOCCI, G.; SCALDAFERRI, F.; BONIZZI, M.; FELICE, C.; ANDRISANI, G.; GASBARRINI, A. // European Review for Medical & Pharmacological Sciences;Jan2009 Supplement, Vol. 13 Issue S-1, p33 

    In the last decade, biologic agents, in particular infliximab and adalimumab, have deeply changed the therapeutic armamentarium of inflammatory bowel disease (IBD). However, these drugs have a number of contraindications and side-effects that physicians should know so to avoid and eventually...

  • Inflammatory bowel disease posters.  // Gut;Apr2005 Supplement 2, Vol. 54, pA89 

    The article presents information on abstracts related to inflammatory bowel disease. An abstract presents information on the faecal calprotectin in the management of IBD and in the assessment of patients with LBS. Calprotectin is a neutrophil derived protein that is stable in stool. It shows...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics